TY - JOUR
T1 - Checklist for studies of HIV drug resistance prevalence or incidence
T2 - rationale and recommended use
AU - Mbuagbaw, Lawrence
AU - Garcia, Cristian
AU - Brenner, Bluma
AU - Cecchini, Diego
AU - Chakroun, Mohamed
AU - Djiadeu, Pascal
AU - Holguin, Africa
AU - Mor, Orna
AU - Parkin, Neil
AU - Santoro, Maria M.
AU - Ávila-Ríos, Santiago
AU - Fokam, Joseph
AU - Phillips, Andrew
AU - Shafer, Robert W.
AU - Jordan, Michael R.
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/10
Y1 - 2023/10
N2 - HIV drug resistance (HIVDR) is a major challenge to the effectiveness of antiretroviral therapy. Global efforts in addressing HIVDR require clear, transparent, and replicable reporting in HIVDR studies. We describe the rationale and recommended use of a checklist that should be included in reports of HIVDR incidence and prevalence. After preliminary consultations with experts on HIVDR and establishing the need for guidance on HIVDR reporting, we used a sequential, explanatory, mixed methods approach to create the checklist; together with the accompanying articles, the checklist was reviewed by the authors and validated externally. The checklist for studies on HIVDR prevalence or incidence (CEDRIC-HIV) includes 15 recommended items that would enhance transparency and facilitate interpretation, comparability, and replicability of HIVDR studies. CEDRIC-HIV will help authors of HIVDR studies prepare research reports and assist reviewers and editors in assessments of completeness of reporting. The checklist will also facilitate statistical pooling and interpretation of HIVDR data.
AB - HIV drug resistance (HIVDR) is a major challenge to the effectiveness of antiretroviral therapy. Global efforts in addressing HIVDR require clear, transparent, and replicable reporting in HIVDR studies. We describe the rationale and recommended use of a checklist that should be included in reports of HIVDR incidence and prevalence. After preliminary consultations with experts on HIVDR and establishing the need for guidance on HIVDR reporting, we used a sequential, explanatory, mixed methods approach to create the checklist; together with the accompanying articles, the checklist was reviewed by the authors and validated externally. The checklist for studies on HIVDR prevalence or incidence (CEDRIC-HIV) includes 15 recommended items that would enhance transparency and facilitate interpretation, comparability, and replicability of HIVDR studies. CEDRIC-HIV will help authors of HIVDR studies prepare research reports and assist reviewers and editors in assessments of completeness of reporting. The checklist will also facilitate statistical pooling and interpretation of HIVDR data.
UR - http://www.scopus.com/inward/record.url?scp=85172882170&partnerID=8YFLogxK
U2 - 10.1016/S2352-3018(23)00173-X
DO - 10.1016/S2352-3018(23)00173-X
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 37716367
AN - SCOPUS:85172882170
SN - 2352-3018
VL - 10
SP - e684-e689
JO - The Lancet HIV
JF - The Lancet HIV
IS - 10
ER -
